11,12-DiHETrE
11,12-DiHETrE is a dihydroxy fatty acid metabolite of Arachidonic Acid (HY-109590). 11,12-DiHETrE is converted to 11,12-DiHETrE under elevated soluble epoxide hydrolase (sEH) activity, a process closely related to inflammation and oxidative stress. 11,12-DiHETrE can serve as a single biomarker to differentiate between NAFL (non-alcoholic fatty liver disease) and NASH (non-alcoholic steatohepatitis). 11,12-DiHETrE can be used in studies on preterm birth, autism, and pulmonary hypertension.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 192461-95-3
- 分子式: C20H34O4
- 分子量:338.48
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
11,12-DiHETrE can serve as a pharmacodynamic biomarker for soluble epoxide hydrolase (sEH) inhibitors: its levels decrease after administration of sEH inhibitors[1].
11,12-DiHETrE concentrations in plasma of patients with non-alcoholic steatohepatitis (NASH) are significantly higher than those in patients with non-alcoholic fatty liver (NAFL) and healthy controls[2].
11,12-DiHETrE is significantly positively correlated with the presence of resting pulmonary arterial hypertension[3].
The higher the exposure level of 11,12-DiHETrE in umbilical cord blood, the more likely it is for individuals to present with severe autism spectrum disorder (ASD) symptoms[4].
Elevated levels of 11,12-DiHETrE reflect an imbalance in the pro-resolving/anti-inflammatory pathway[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 192461-95-3
-
分子量 338.48
-
分子式 C20H34O4
-
SMILES
CCCCC/C=C\CC(O)C(O)C/C=C\C/C=C\CCCC(O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Svenvik M, et al. Plasma oxylipin levels associated with preterm birth in preterm labor. Prostaglandins Leukot Essent Fatty Acids. 2021 Mar;166:102251. [Content Brief]
[2]. Loomba R, et al. Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis. J Lipid Res. 2015 Jan;56(1):185-92. [Content Brief]
[3]. McNeill JN,et al. The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension. Eur Respir J. 2023 Oct 19;62(4):2300561. [Content Brief]
[4]. Hirai T, et al. Arachidonic acid-derived dihydroxy fatty acids in neonatal cord blood relate symptoms of autism spectrum disorders and social adaptive functioning: Hamamatsu Birth Cohort for Mothers and Children (HBC Study). Psychiatry Clin Neurosci. 2024 Sep;78(9):546-557. [Content Brief]
[5]. Sala-Climent M, et al. Oxylipin serum profile changes in response to an open-label anti-inflammatory dietary intervention. Clin Nutr ESPEN. 2025 Aug;68:389-402. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
11,12-DiHETrE 関連分類
HY-113111 関連分類
Powered by Bioz